These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22158330)

  • 21. [Efficacy and safety of indacaterol - new long-acting beta(2) agonist].
    Chazan R
    Pneumonol Alergol Pol; 2010; 78(3):229-35. PubMed ID: 20461692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic variations in scavenger and β₂-adrenergic receptors and risk of pulmonary disease.
    Thomsen M
    Dan Med J; 2014 Sep; 61(9):B4910. PubMed ID: 25186548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Indacaterol (Onbrez Breezhaler), oral inhalation].
    Duh D; Tanret I
    J Pharm Belg; 2011 Dec; (4):127-8. PubMed ID: 22299240
    [No Abstract]   [Full Text] [Related]  

  • 24. Beta2-adrenergic receptor haplotype and bronchodilator response to salbutamol in patients with acute exacerbations of COPD.
    Mokry M; Joppa P; Slaba E; Zidzik J; Habalova V; Kluchova Z; Micietova L; Rozborilova E; Salagovic J; Tkacova R
    Med Sci Monit; 2008 Aug; 14(8):CR392-8. PubMed ID: 18667995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coexisting Heart Failure and Chronic Obstructive Pulmonary Disease: Report of Two Cases Treated with Indacaterol/Glycopyrronium.
    Cosentino ER; Degli Esposti D; Miceli R; Bentivenga C; Landolfo M; Ricci Iamino I; Spinardi L; Magri G; Borghi C
    Respiration; 2018; 95 Suppl 1():3-5. PubMed ID: 29705784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta
    Hussein MH; Sobhy KE; Sabry IM; El Serafi AT; Toraih EA
    Adv Med Sci; 2017 Mar; 62(1):193-201. PubMed ID: 28327457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphic variants of the beta2-adrenergic receptor (ADRB2) gene and ADRB2-related propanolol-induced dyslipidemia in the Colombian population.
    Isaza C; Henao J; Ramirez E; Cuesta F; Cacabelos R
    Methods Find Exp Clin Pharmacol; 2005 May; 27(4):237-44. PubMed ID: 16082424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms of IL4, IL13, and ADRB2 genes in COPD.
    Hegab AE; Sakamoto T; Saitoh W; Massoud HH; Massoud HM; Hassanein KM; Sekizawa K
    Chest; 2004 Dec; 126(6):1832-9. PubMed ID: 15596681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indacaterol: a novel long-acting β(2) -agonist.
    Ray SM; McMillen JC; Treadway SA; Helmer RS; Franks AS
    Pharmacotherapy; 2012 May; 32(5):456-74. PubMed ID: 22499359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indacaterol. A long-acting beta-2 agonist, no advantages in COPD.
    Prescrire Int; 2011 Sep; 20(119):201-5. PubMed ID: 21954512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bronchodilator efficacy of indacaterol, a novel once-daily beta2-agonist, in patients with persistent asthma.
    Pearlman DS; Greos L; LaForce C; Orevillo CJ; Owen R; Higgins M
    Ann Allergy Asthma Immunol; 2008 Jul; 101(1):90-5. PubMed ID: 18681090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta2-adrenergic receptor polymorphisms as a determinant of preferential bronchodilator responses to β2-agonist and anticholinergic agents in Japanese patients with chronic obstructive pulmonary disease.
    Konno S; Makita H; Hasegawa M; Nasuhara Y; Nagai K; Betsuyaku T; Hizawa N; Nishimura M
    Pharmacogenet Genomics; 2011 Nov; 21(11):687-93. PubMed ID: 21881540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CT scanning-based phenotypes vary with ADRB2 polymorphisms in chronic obstructive pulmonary disease.
    Kim WJ; Oh YM; Sung J; Lee YK; Seo JB; Kim N; Kim TH; Huh JW; Lee JH; Kim EK; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Kwon SY; Lee SD
    Respir Med; 2009 Jan; 103(1):98-103. PubMed ID: 18789663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. QVA149 demonstrates superior bronchodilation compared with indacaterol or placebo in patients with chronic obstructive pulmonary disease.
    van Noord JA; Buhl R; Laforce C; Martin C; Jones F; Dolker M; Overend T
    Thorax; 2010 Dec; 65(12):1086-91. PubMed ID: 20978028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1.
    Brøgger J; Steen VM; Eiken HG; Gulsvik A; Bakke P
    Eur Respir J; 2006 Apr; 27(4):682-8. PubMed ID: 16585076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indacterol (Arcapta Neohaler) for COPD.
    Med Lett Drugs Ther; 2012 Apr; 54(1389):33-5. PubMed ID: 22538621
    [No Abstract]   [Full Text] [Related]  

  • 37. Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD.
    Buhl R; Dunn LJ; Disdier C; Lassen C; Amos C; Henley M; Kramer B;
    Eur Respir J; 2011 Oct; 38(4):797-803. PubMed ID: 21622587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indacaterol inhibits tumor cell invasiveness and MMP-9 expression by suppressing IKK/NF-κB activation.
    Lee SU; Ahn KS; Sung MH; Park JW; Ryu HW; Lee HJ; Hong ST; Oh SR
    Mol Cells; 2014 Aug; 37(8):585-91. PubMed ID: 25134539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indacaterol Novartis/skyePharma.
    Currie GP
    Curr Opin Investig Drugs; 2006 May; 7(5):457-63. PubMed ID: 16729723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. beta2-Adrenergic receptor gene polymorphism is associated with mortality in septic shock.
    Nakada TA; Russell JA; Boyd JH; Aguirre-Hernandez R; Thain KR; Thair SA; Nakada E; McConechy M; Walley KR
    Am J Respir Crit Care Med; 2010 Jan; 181(2):143-9. PubMed ID: 19850944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.